Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor
暂无分享,去创建一个
H. Loetscher | T. Espevik | M. Brockhaus | R. Shalaby | U. Nonstad | T. Espevik | Manfred Brockhaus | Refaat Shalaby
[1] H. Hohmann,et al. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). , 1989, The Journal of biological chemistry.
[2] A. Waage,et al. Cytokine regulation of interleukin 6 production by human endothelial cells. , 1989, Cellular immunology.
[3] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.
[4] T. Espevik,et al. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1. , 1988, Journal of immunology.
[5] T. Espevik,et al. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha , 1987, The Journal of experimental medicine.
[6] R. Locksley,et al. Tumor necrosis factors α and β differ in their capacities to generate interleukin 1 release from human endothelial cells , 1987 .
[7] A. Fauci,et al. Effect of tumor necrosis factor alpha on mitogen-activated human B cells , 1987, The Journal of experimental medicine.
[8] R. Yamamoto,et al. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. E. Carver,et al. Serum-free in vitro bioassay for the detection of tumor necrosis factor. , 1986, Journal of immunological methods.
[10] N. Ruddle. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1986, Journal of immunology.
[11] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[12] J. Vilček,et al. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors , 1986, The Journal of experimental medicine.
[13] J. Gamble,et al. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[14] B. Aggarwal,et al. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon , 1985, Nature.
[15] B. Aggarwal,et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.
[16] B. Aggarwal,et al. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1985, Journal of immunology.
[17] B. Aggarwal,et al. Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin , 1985, International journal of cancer.
[18] Bharat B. Aggarwal,et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.
[19] G. Nicolson,et al. Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and immobilized streptavidin matrices. , 1984, Journal of immunological methods.
[20] G. Striker,et al. Factors influencing endothelial cell proliferation in vitro , 1978, Journal of cellular physiology.